Loading company…
Shenzhen Lvye develops and markets innovative medicines, including anti-cancer drugs.
Founded in 2023 and based in Shenzhen, China, Shenzhen Lvye is a Luye Pharma Group subsidiary focused on developing and marketing anti-cancer drugs. Its products include drug delivery systems such as microspheres, liposomes, and transdermal delivery, along with molecular entities and biological antibodies. In July 2024, it raised CNY 1.6 billion in strategic investment to support working capital, staffing, and research and development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in